Prairie Village, KS – According to filings with the U.S. Securities and Exchange Commission, Artio Medical is raising $36,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Nicholas Franano played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Artio Medical
ARTIO MEDICAL is developing innovative new medical devices to treat important unmet medical needs for large, global peripheral vascular, neurovascular, and structural heart markets. These products have the potential to enable physicians to perform better, safer, and faster procedures, while improving patient outcomes and reducing costs. Delivering innovative medical devices with the potential to provide impactful solutions to important unmet medical needs in the peripheral vascular, neurovascular, and structural heart markets. When treating and preventing vascular diseases, physicians often must stop or redirect the flow of blood in arteries and veins. Artio is developing peripheral vascular embolization devices designed for precision placement and immediate occlusion. At Artio, we are committed to developing and commercializing novel, best-in-class medical devices that have the potential to provide better patient outcomes.

To learn more about Artio Medical, visit http://artiomedical.com/

Contact:
Nicholas Franano, President and Chief Executive Officer
913-730-0175
nfranano@artiomedical.com
https://www.linkedin.com/in/nicholasfranano/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved